Aura Biosciences Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Aura Biosciences is a clinical-stage biotechnology company in the biotechnology research industry focused on developing precision therapies for solid tumors intended to preserve organ function. Its lead candidate bel-sar AU-011 is in late-stage development for early choroidal melanoma and in early-stage development for other ocular oncology indications and bladder cancer. The company is headquartered in Boston, Massachusetts, and has between 51 and 200 employees. In 2026, Aura Biosciences appointed Natalie Holles as Chief Executive Officer and President, and the company announced a public offering that raised approximately 299 million in proceeds. Aura Biosciences is publicly traded on NASDAQ under the ticker AURA and maintains a corporate website at aurabiosciences.com.